Serco Group plc (SRP.L) Bundle
Investors seeking a sharp, numbers-driven snapshot of Serco Group plc will want to dig into how the business delivered £4.9 billion of revenue in fiscal 2025 (up 3% at constant currency with 1% organic growth), powered by a standout 11% organic rise in defense revenue that now represents over 40% of group sales, while North America grew organically by 9% and Asia Pacific slipped 3% after Australia immigration contracts ended; order intake reached roughly £5.5 billion with a book-to-bill of at least 110% and a record pipeline of £11.9 billion of opportunities, underpinning upgrades such as Berenberg's new £3.00 target and sustained shareholder returns including buybacks (£140m in 2024 and a £50m program in Dec 2025), even as balance-sheet metrics show adjusted net debt of £259 million (leverage ~0.9x) alongside a very strong 2024 free cash flow of £228 million, all against headwinds like a £6m currency translation drag, contract mobilization costs and Asia Pacific contract conclusions that investors should weigh when reading on
Serco Group plc (SRP.L) - Revenue Analysis
Serco Group plc reported revenue of £4.9 billion for the fiscal year 2025, representing a 3% increase at constant currency, including 1% organic growth. The topline growth was driven by stronger performance in North America and defense, while Asia Pacific weighed on organic progress due to contract exits in Australia.- Reported revenue (FY2025): £4.9 billion (3% cc increase; 1% organic)
- Order intake / contract awards: ~£5.5 billion, delivering a book-to-bill of at least 110%
- New opportunities pipeline: £11.9 billion (decade high)
| Metric | Value (FY2025) | Comment |
|---|---|---|
| Total revenue | £4.9bn | +3% at constant currency; +1% organic |
| North America organic growth | +9% | Major contributor to group growth |
| Defense organic growth | +11% | Now >40% of group revenue |
| Asia Pacific organic change | -3% | Impact from Australia immigration contract conclusions |
| Order intake | ~£5.5bn | Book-to-bill ≥110% |
| Opportunities pipeline | £11.9bn | Decade-high level |
- Defense expansion - organic growth of 11% increased defense's share to over 40% of group revenue, shifting the revenue mix toward higher-margin, long-duration contracts.
- North America momentum - 9% organic growth reflecting contract wins and expansions across federal and state services.
- Order book strength - £5.5bn in new contract awards and a book-to-bill ≥110% support near-term revenue visibility.
- Pipeline health - £11.9bn of opportunities provides a multi-year runway for revenue growth and potential margin uplift.
- Europe & UK: steady performance with selective renewals and extensions; revenue contribution remains significant but slower organic expansion versus North America.
- North America: fastest-growing region this year; primary engine for organic growth and new wins.
- Asia Pacific: -3% organic decline driven largely by Australia immigration contract exits; temporary headwind to group organic growth.
- Defense: now over 40% of revenue - raises strategic exposure to government defence budgets and program timing.
- Higher proportion of defense and North America work increases forward visibility but can concentrate exposure to a smaller set of large government customers.
- Strong book-to-bill and record pipeline suggest revenue momentum, subject to successful conversion of pipeline into awarded contracts.
Serco Group plc (SRP.L) - Profitability Metrics
Serco's recent results show a mix of underlying operational improvement and reported volatility from non-cash items, with clear regional strengths and shareholder returns edging higher.- Underlying operating profit (2025): approximately £270 million (up from £260 million), underlying margin ~5.5%.
- Underlying operating profit margin (2024): improved by 60 basis points to 5.6%, driven by efficiency and productivity measures.
- North America segment underlying operating profit margin: 10.6%, indicating strong regional performance.
- Reported operating profit (2024): £130 million, reduced by an exceptional £115 million non-cash goodwill impairment in Asia Pacific.
- Underlying earnings per share (H1 2025): increased 12% to 9.60 pence.
- Interim dividend per share (H1 2025): raised 8% to 1.45 pence.
| Metric | Period | Value | Notes |
|---|---|---|---|
| Underlying operating profit | 2025 | £270m | Up from £260m in prior period; margin ~5.5% |
| Underlying operating profit margin | 2024 | 5.6% | Improved by 60 basis points vs prior year |
| Reported operating profit | 2024 | £130m | Includes £115m non-cash goodwill impairment (Asia Pacific) |
| North America operating profit margin | Most recent | 10.6% | Best-performing regional margin |
| Underlying EPS | H1 2025 | 9.60p | Up 12% year-on-year |
| Interim dividend per share | H1 2025 | 1.45p | Raised 8% |
- Margin drivers: cost-efficiency programs, productivity initiatives and stronger North America contract mix.
- Reported vs underlying: one-off impairments (notably £115m goodwill in Asia Pacific) materially depress reported profit despite underlying operational gains.
- Shareholder returns: modest dividend increase alongside rising underlying EPS supports a cautiously constructive income profile.
Serco Group plc (SRP.L) - Debt vs. Equity Structure
Serco's capital structure through mid-2025 shows a material shift toward higher reported leverage while management has continued active shareholder returns and signalled discipline on capital allocation.| Metric | 2024 (Reported) | H1 2025 (Reported) | 30 Jun 2025 (Adjusted) | Dec 2025 (Action) |
|---|---|---|---|---|
| Reported Net Debt | £? (context: adjusted net debt £100m) | £783m (up 24% YoY) | £259m (adjusted) | - |
| Adjusted Net Debt | £100m | - | £259m | - |
| Net Debt / EBITDA (Leverage) | ~0.3x (adjusted) | - | ~0.9x (adjusted) | - |
| Share Buybacks (period) | £140m (2024) | - | - | £50m (Dec 2025) |
| Total Buybacks since 2021 | £340m (after 2024) | - | - | £390m (after Dec 2025) |
- Adjusted net debt rose to £259m by 30 June 2025 with leverage around 0.9x net debt/EBITDA - a clear step-up from adjusted 2024 leverage of ~0.3x (adjusted net debt £100m).
- Reported net debt in H1 2025 increased 24% to £783m, reflecting timing, working capital and/or accounting items that create a gap between reported and adjusted measures.
- Shareholder distributions remain meaningful: a £140m buyback in 2024 and a subsequent £50m buyback in Dec 2025 bring cumulative buybacks to £390m since 2021, illustrating a return-focused capital allocation stance.
- The Board has signalled it will review the capital position at the full year in line with stated capital allocation priorities, implying potential for further buybacks, dividends or debt actions depending on end-of-year metrics.
- Leverage profile: Adjusted leverage rising from ~0.3x to ~0.9x materially changes financial flexibility - still modest by corporate standards but meaningfully higher.
- Liquidity and covenant risk: The divergence between reported net debt (£783m) and adjusted net debt (£259m) necessitates scrutiny of working capital, lease liabilities and one-off items that drive reported figures.
- Capital allocation trade-offs: Continued buybacks (total £390m since 2021) have returned cash to equity holders but also coincide with higher adjusted leverage, tightening the buffer for operational volatility.
- Governance signal: The Board's commitment to review capital at year-end suggests management remains attentive to balancing growth investment, de-risking the balance sheet and shareholder returns.
Serco Group plc (SRP.L) - Liquidity and Solvency
Serco Group plc displays a robust liquidity and solvency profile driven by strong cash generation, conservative leverage and explicit capital allocation discipline. Key 2024-2025 metrics underline a balance between reinvestment, de-leveraging and shareholder returns while preserving flexibility for contract and bidding cycles.- Free cash flow: £228m generated in 2024 (ahead of ~£170m guidance); 2025 guidance raised to £170m.
- Trading cash conversion: >100% average since 2019 (vs medium‑term target of 80%+).
- Operating cash inflow: Net cash from operating activities £419m in 2024 (+7% year‑on‑year).
- Adjusted net debt: £100m at year‑end 2024 - £45m better than prior guidance.
- Leverage: ~0.3x net debt/EBITDA at 2024 year‑end; 2025 target/statement citing ~0.9x for guidance context.
- Capital allocation: Board to review capital position at the full year in line with priorities.
| Metric | 2024 Reported | Guidance / Target | Notes |
|---|---|---|---|
| Free cash flow | £228m | £170m (2025 guidance) | 2024 outperformed guidance by £58m |
| Net cash from operations | £419m | - | Up 7% vs prior year |
| Adjusted net debt | £100m | - | £45m lower than previous guidance |
| Leverage (net debt / EBITDA) | ~0.3x | ~0.9x (context for 2025) | Well below typical covenant thresholds; gives headroom |
| Trading cash conversion (since 2019) | >100% average | 80%+ | Consistent cash efficiency vs medium‑term target |
- Strong operating cash inflows (£419m) underpin working capital and capital expenditure needs.
- Low adjusted net debt (£100m) provides capacity for targeted M&A or further shareholder returns, subject to Board review.
- High cash conversion (>100%) reduces refinancing risk and supports deleveraging even with cyclical revenue variability.
Serco Group plc (SRP.L) Valuation Analysis
Serco Group plc's valuation trajectory over recent years has been shaped by steady revenue growth, active capital returns and a growing pipeline of contracted work. Key moves by management and analyst upgrades have underpinned investor sentiment and market capitalization improvements.- Berenberg upgraded its price target to £3.00 from £2.70, citing strong operational performance and a robust order book.
- Management enacted significant buybacks: £140 million in 2024 and an additional £50 million announced in December 2025, taking total buybacks since 2021 to £340 million.
- Interim dividend per share rose by 8% to 1.45 pence in H1 2025, signaling confidence in cash generation and payout sustainability.
- Record pipeline and strong order intake continue to support forward valuation multiples.
| Metric | Value / Note |
|---|---|
| Berenberg price target (Dec 2025) | £3.00 (up from £2.70) |
| Share buybacks | £140m (2024) + £50m (Dec 2025); total £340m since 2021 |
| Interim dividend (H1 2025) | 1.45 pence per share (↑8%) |
| Order book / Pipeline | Record pipeline and strong order intake (company disclosure) |
| Market drivers | Consistent revenue growth, strategic acquisitions, contract renewals |
- Buybacks: enhance per-share metrics and reflect management view that shares were undervalued when executed.
- Dividend increase: an 8% rise to 1.45p in H1 2025 demonstrates cashflow confidence.
- Order book: large, visible pipeline underpins forward revenue visibility and justifies premium to peers in certain scenarios.
Serco Group plc (SRP.L) - Risk Factors
Key risk factors that could materially affect Serco Group plc's (SRP.L) financial performance, cash flow and investor returns are summarized below.
- Regional revenue contractions: Asia Pacific reported a 3% organic decline in revenue in the latest period, driven largely by the scheduled conclusion of Australia immigration contracts.
- Contract mobilization and execution costs: Elevated mobilization costs-most notably on the electronic monitoring contract-have eroded near-term margins and increased working capital requirements.
- Geopolitical and fiscal exposure: Dependence on government contracts exposes Serco to geopolitical complexities and sovereign fiscal pressures that can prompt contract renegotiation, deferrals or early termination.
- Acquisition and integration risk: The MT&S acquisition carries integration risk (operational disruption, cultural alignment, systems consolidation), although it is expected to enhance defense services capability over time.
- Currency translation and FX volatility: Serco faces exchange-rate exposure; management estimates an approximate £6 million translation headwind in 2025 vs prior expectations.
- Contract lifecycle effects: The scheduled conclusion of specific regional contracts (e.g., in Asia Pacific) creates near-term revenue gaps and potential margin pressure until new awards or extensions are secured.
Quantitative snapshot of key near-term risk impacts (management estimates / reported figures):
| Risk Item | Reported / Estimated Impact | Timeframe |
|---|---|---|
| Asia Pacific organic revenue decline | 3% decline in organic revenue | Most recent reporting period |
| Electronic monitoring contract mobilization costs | Significant one-off mobilization costs; impact on operating margin (quantified as material to the period) | Current contract ramp-up |
| Currency translation headwind | Estimated £6 million adverse impact | FY 2025 |
| MT&S integration | Operational integration risk; potential short-term cost increase, medium-term capability gain | Integration period following acquisition |
| Contract conclusions (e.g., Australia immigration) | Reduced revenue contribution; pressure on segment topline | Ongoing / near term |
| Geopolitical / fiscal pressures | Risk of renegotiation, deferred payments, or contract termination; impact varies by jurisdiction | Ongoing |
Risk management considerations and potential investor questions:
- How management plans to offset the 3% Asia Pacific organic decline via new awards, upsells or cost reductions.
- Details and expected run-rate of mobilization costs for electronic monitoring and whether these are one-off or recurring.
- Integration milestones, projected synergies and contingency plans for MT&S.
- Hedging strategy and sensitivity analysis around the ~£6m FX translation headwind in 2025.
- Contract pipeline and tender win-rate to replace revenue from concluded contracts.
For broader context on Serco's strategy, history and how it makes money, see: Serco Group plc: History, Ownership, Mission, How It Works & Makes Money
Serco Group plc (SRP.L) - Growth Opportunities
Serco's positioning across defense, government services and technology-enabled solutions highlights multiple growth vectors driven by contract wins, acquisitions and operational improvements.- Defense: organic revenue growth of 11%, now representing over 40% of total revenue, driven by expanded military services and program renewals.
- Pipeline: record £11.9 billion of new opportunities across core markets, providing multi-year revenue visibility.
- Acquisitions & capability build: MT&S acquisition to bolster technology-enabled military training and satellite ground network software services.
- Regional momentum: North America delivered 9% organic growth with strong order intake, underpinning expansion in the largest addressable market.
- Operational leverage: ongoing efficiency and productivity initiatives aimed at margin improvement and scalable delivery.
- Capital returns: £50 million share buyback program alongside an increased interim dividend, signaling board confidence in cash generation and balance sheet strength.
| Metric | Value / Detail |
|---|---|
| Defense organic revenue growth | +11% |
| Defense share of total revenue | >40% |
| Pipeline of opportunities | £11.9 billion |
| North America organic growth | +9% |
| Share buyback | £50 million |
| Dividend action | Interim dividend increased (company announced) |
| Strategic acquisition | MT&S - tech-enabled military training & satellite ground network software |
| Key operational focus | Efficiency & productivity improvements to support margin growth |
- How these elements interact: the large pipeline and defense weighting create revenue scalability; MT&S adds higher-margin, software-enabled service lines; North America growth and efficiency programs improve margin conversion; buybacks/dividend increases return cash while signaling financial confidence.

Serco Group plc (SRP.L) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.